ArticleAntiviral chemistry & chemotherapy

Virologic failure after 48 weeks of raltegravir-based regimen in low HIV-1 incidence setting.

Wassim Chehadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.